Factors Influencing Morbidity Trends in BRIC CountriesDecision ResourcesDecember 1, 2011 SKU: DECR6727327 |
More Oncology/Hematology reports by Decision Resources
TreatmentTrends®: Advanced/Metastatic Breast Cancer (US) 2012 by Decision Resources
This report series examines the current trends in the management of Advanced / Metastatic Breast Cancer from the perspective of medical oncologists. TreatmentTrends® are syndicated ...
Breast Cancer in Mexico by Decision Resources
Over the next decade, the diagnosed incidence of breast cancer (CaB) in Mexico will increase at almost three times the average annual growth ...
Oncology Patient Flow Model: Ovarian Cancer by Decision Resources
Query multiple epidemiological parameters over a 20 year forecast period in a data rich, graphical and interactive environment with Pharmacor Patient Flow Models.Please ...
Ovarian Cancer by Decision Resources
See all reports like this >>Few novel therapies have entered the ovarian cancer (CaO) market in recent history, and oncologists are particularly keen to welcome new market entrants ...
More Brazil Oncology/Hematology reports
Payer and Clinician Perspectives on the Role of Premium-Priced Angiogenesis Inhibitors in Brazil and Mexico by Decision Resources
This Emerging Markets Physician and Payer Forum explores dynamics that affect sales of angiogenesis inhibitors in Brazil and Mexico, and dynamics that will ...
Gastric Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis to 2020 by GlobalData
Gastric Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis to 2020SummaryGlobalData, the industry analysis specialist, has released its new report, ...
Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 by GlobalData
Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData's pharmaceutical report, “Prostate Cancer - Brazil, Russia, India and China ...
Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 by GlobalData
See all reports like this >>Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020SummaryGlobalData, the industry analysis specialist, has released its new ...
More Brazil reports
D&B Country RiskLine Report: Brazil by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Spirits - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Spirits - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) ...
Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering the Chemicals ...
Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
See all reports like this >>Datamonitor's Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Oncology/Hematology Reports
